Posts tagged “GSK”
Tech links: IBM's cognitive dress; Cisco cloud phone; Watson on Twilio; GSK lung drug success; Lenovo Moto Z
In today's roundup of Tech Links, taking you to important stories affecting tech in the Triangle: Check out the "cognitive dress" designed in part by IBM's Watson; see a YouTube video about the fashion project; read about Cisco's cloud phone; find out about new Watson services for developers at Twilio, GSK gets good news on a potential lung drug; and Lenovo trademarks Moto Z.
Tech links: 'Watson' at Moogest; free Cisco IoT training; AT&T connects cars; Red Hat bitcoin; Epic grants; China drug prices
In today's tech Links roundup of news affecting Triangle companies: IBM's Watson at Moogfest; Cisco plans free IoT training online; AT&T links cars and data; Red Hat offers more details on its bitoin initiative; Epic Games awards $75,000 in grants; and China slashes prices for GSK, AstraZeneca drugs.
Triangle headlines: GSK sells RTP buildings; Nortel bankruptcy ruling; Lenovo's $500M investment fund; Chinese firms like NC
In today's wrapup of Triangle area news: GSK sells its RTP buildings but plans to lease them back; a ruling may lead to Nortel bankruptcy settlement; Lenovo plans to invest $500 million in startups; and Chinese firms show a liking for North Carolina.
Pharmaceutical company GlaxoSmithKline says higher sales of vaccines and consumer healthcare products pushed up its earnings from core business by 19 percent in the first quarter. CEO Andrew Witty sees the results as an "encouraging start" for the year.
Drug giant GlaxoSmithKline made news official what had been rumored for months: CEO Andrew Witty is going to retire. Witty plans to step down a year from now. However, he says his decision is not linked to investor calls for breakup of the company.
Drug giant GlaxoSmithKline made news official what had been rumored for months: CEO Andrew Witty is going to retire. Witty plans to step down a year from now.
Drug giant GlaxoSmithKline is preparing to launch what is called a "formal search" for a successor to Chief Executive Officer Andrew Witty, reports the prestigious Financial Times as well as the Reuters news service.
GlaxoSmithKline is boosting its own efforts to fight AIDS by closing on a deal to buy the HIV drug pipeline of Bristol-Myers Squibb . The transaction is worth as much as $1.46 billion. In May, GSK said it would invest $20 million in a deal with UNC-Chapel Hill to develop an AIDS cure.
British-based drugmaker GlaxoSmithKline (NYSE: GSK) posted a loss of $616 million for the fourth quarter of 2015 - compared with a profit of over $1 for the same period a year earlier- as the company moved to integrate new businesses. Its top exec says GSK is making progress.
GlaxoSmithKline, which is under growing investor pressure to improve its financials, is investing alongside Johnson & Johnson in another startup fund. For the second time in a week, GSK moves to back new and emerging ventures in hopes of driving future growth.
In today's Bulldog wrapup of technology and life science news: Sprint is cutting jobs and closing six call centers; another security problem for Lenovo; investor pressure mounts for change at GSK; and Arista counter-sues Cisco.
In today's Bulldog wrapup of technology and life science news: Lenovo fights lawsuits over adware; Google pays back taxes in U.K.; GSK puts $15 million in new university drug development fund; and Novozymes launches a poultry product with French partner.
A woman who is a twin sister of a former scientists at GSK is charged conspiracy to steal secrets from the drug giant. The sister, who was fired recently by GSK, also is charged along with three others.
New GSK drug's price criticized; Google expands in Tennessee; 'Dotcom' faces extradition; Turing seeks CEO
In today's Bulldog wrapup of technology and life science news: An independent group is criticizing the price of GSK's new asthma drug; Google to invfest $600 million in Tennessee data center expansion; Kim Dotcom faces extradition to the U.S.; and drug company Turing is looking for a new CEO to replace Martin Shkreli.
GlaxoSmithKline is boosting its own efforts to fight AIDS by agreeing to buy the HIV drug pipeline of Bristol-Myers Squibb in a deal valued at as much as $1.46 billion. In May, GSK said it would invest $20 million in a deal with UNC-Chapel Hill to develop an AIDS cure.
GSK arthritis drug advances; Washington sues tech support firm; streaming music fees go up; FDA OKs cheaper diabetes drug
In today's Bulldog wrapup of technology and life science news: A new arthritis drug from GSK moves toward regulatory approval; the state of Washington is suing tech support firm iYogi, alleging it scams customers; streaming music fees are going up; and the FDA approves a cheaper diabetes drug.